BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. BMC Med 2018;16:73. [PMID: 29779492 DOI: 10.1186/s12916-018-1053-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Mekota AM, Gillespie SH, Hoelscher M, Diacon AH, Dawson R, Churchyard G, Sanne I, Minja L, Kibiki G, Maboko L, Lakhi S, Joloba M, Alabi A, Kirenga B, McHugh TD, Grobusch MP, Boeree MJ; PanACEA consortium. Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach. Acta Trop 2023;238:106776. [PMID: 36502888 DOI: 10.1016/j.actatropica.2022.106776] [Reference Citation Analysis]
2 Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, Holtzman D, Imperial M, Cirillo DM, Gillespie SH, Ruhwald M; UNITE4TB Consortium. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clin Microbiol Rev 2022;:e0022721. [PMID: 35311552 DOI: 10.1128/cmr.00227-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Q, Peng Z, Fu X, Wang H, Zhao Z, Pang Y, Chen L. Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis. BMC Infect Dis 2022;22:256. [PMID: 35287590 DOI: 10.1186/s12879-021-06967-y] [Reference Citation Analysis]
4 Sidamo T, Shibeshi W, Yimer G, Aklillu E, Engidawork E. Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study. Infect Drug Resist 2021;14:5473-89. [PMID: 34984005 DOI: 10.2147/IDR.S342964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 李 星. Progress in Imaging Studies of Bacterial-Positive Pulmonary Tuberculosis. ACM 2022;12:7238-7243. [DOI: 10.12677/acm.2022.1281045] [Reference Citation Analysis]
6 Muefong CN, Owolabi O, Donkor S, Charalambous S, Mendy J, Sey ICM, Bakuli A, Rachow A, Geldmacher C, Sutherland JS. Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients. Front Immunol 2021;12:740933. [PMID: 34887853 DOI: 10.3389/fimmu.2021.740933] [Reference Citation Analysis]
7 Liu Q, Li R, Li Q, Luo B, Lin J, Lyu L. High levels of plasma S100A9 at admission indicate an increased risk of death in severe tuberculosis patients. J Clin Tuberc Other Mycobact Dis 2021;25:100270. [PMID: 34849408 DOI: 10.1016/j.jctube.2021.100270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kim SH, Shin YM, Yoo JY, Cho JY, Kang H, Lee H, Choe KH, Lee KM, Yang B. Clinical Factors Associated with Cavitary Tuberculosis and Its Treatment Outcomes. J Pers Med 2021;11:1081. [PMID: 34834433 DOI: 10.3390/jpm11111081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Mbelele PM, Sauli E, Mpolya EA, Mohamed SY, Addo KK, Mfinanga SG, Heysell SK, Mpagama S. TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis. Trop Med Int Health 2021;26:1057-67. [PMID: 34107112 DOI: 10.1111/tmi.13638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Namugenyi J, Musaazi J, Katamba A, Kalyango J, Sendaula E, Kambugu A, Fehr J, Castelnouvo B, Manabe YC, Ssengooba W, Sekaggya-Wiltshire C. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. BMC Infect Dis 2021;21:513. [PMID: 34074248 DOI: 10.1186/s12879-021-06220-6] [Reference Citation Analysis]
11 Machowski EE, Letutu M, Lebina L, Waja Z, Msandiwa R, Milovanovic M, Gordhan BG, Otwombe K, Friedrich SO, Chaisson R, Diacon AH, Kana B, Martinson N. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis 2021;21:466. [PMID: 34022850 DOI: 10.1186/s12879-021-06133-4] [Reference Citation Analysis]
12 Shao Y, Song H, Li G, Li Y, Li Y, Zhu L, Lu W, Chen C. Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China. Front Cell Infect Microbiol 2021;11:638990. [PMID: 33816342 DOI: 10.3389/fcimb.2021.638990] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Rosenfeld G, Gabrielian A, Wang Q, Gu J, Hurt DE, Long A, Rosenthal A. Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases. PLoS One 2021;16:e0247906. [PMID: 33730021 DOI: 10.1371/journal.pone.0247906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li Q, Peng Z, Fu X, Wang H, Zhao Z, Pang Y, Chen L. Rv3737 is required for Mycobacterium tuberculosis growth in vitro and in vivo and correlates with bacterial load and disease severity in human tuberculosis.. [DOI: 10.1101/2021.01.04.425357] [Reference Citation Analysis]
15 Kan CK, Ragan EJ, Sarkar S, Knudsen S, Forsyth M, Muthuraj M, Vinod K, Jenkins HE, Horsburgh CR, Salgame P, Roy G, Ellner JJ, Jacobson KR, Sahu S, Hochberg NS. Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India. PLoS One 2020;15:e0240595. [PMID: 33332367 DOI: 10.1371/journal.pone.0240595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 George M, Dinant GJ, Kentiba E, Teshome T, Teshome A, Tsegaye B, Spigt M. Evaluation of the performance of clinical predictors in estimating the probability of pulmonary tuberculosis among smear-negative cases in Northern Ethiopia: a cross-sectional study. BMJ Open 2020;10:e037913. [PMID: 33148731 DOI: 10.1136/bmjopen-2020-037913] [Reference Citation Analysis]
17 Lee H, Sohn JW, Sim YS, Shin TR, Kim DG, Choi H. Outcomes of extended duration therapy for drug-susceptible cavitary pulmonary tuberculosis. Ann Transl Med 2020;8:346. [PMID: 32355790 DOI: 10.21037/atm.2020.02.104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Li K, Jiang Z, Zhu Y, Fan C, Li T, Ma W, He Y. A valuable computed tomography-based new diagnostic tool for severe chest lesions in active pulmonary tuberculosis: combined application of influencing factors. Sci Rep 2020;10:2023. [PMID: 32029876 DOI: 10.1038/s41598-020-59041-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ji Y, Cao H, Liu Q, Li Z, Song H, Xu D, Tian D, Qiu B, Wang J. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis 2020;93:84-9. [PMID: 31978585 DOI: 10.1016/j.ijid.2020.01.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
20 Sabiiti W, Azam K, Kuchaka D, Mtafya B, Bowness R, Oravcova K, Farmer ECW, Honeyborne I, Evangelopoulos D, Mchugh TD, Xiao H, Khosa C, Rachow A, Heinrich N, Kampira E, Davies G, Bhatt N, Ntinginya NE, Viegas S, Jani I, Kamdolozi M, Mdolo A, Khonga M, Boeree MJ, Philips PP, Sloan DJ, Hoelscher M, Kibiki GS, Gillespie SH. Improving diagnosis and monitoring of treatment response in pulmonary tuberculosis using the molecular bacterial load assay (MBLA).. [DOI: 10.1101/555995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Tan W, Soodeen-Lalloo AK, Chu Y, Xu W, Chen F, Zhang J, Sha W, Huang J, Yang G, Qin L, Wang J, Huang X, Shi J, Feng Y. Sex influences the association between haemostasis and the extent of lung lesions in tuberculosis. Biol Sex Differ 2018;9:44. [PMID: 30305157 DOI: 10.1186/s13293-018-0203-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]